Skip Navigation
Skip to contents

Intest Res : Intestinal Research

IMPACT FACTOR

Search

Page Path
HOME > Search
3 "Shin-ichiro Hagiwara"
Filter
Filter
Article category
Publication year
Original Articles
Characteristics of monogenic inflammatory bowel disease in very early-onset cases: a Japanese multicenter registry study
Natsuki Ito, Takahiro Kudo, Keisuke Jimbo, Ryusuke Nambu, Fumihiko Kakuta, Tatsuki Mizuochi, Takeshi Saito, Shin-ichiro Hagiwara, Naomi Iwata, Nao Tachibana, Hideki Kumagai, Takashi Ishige, Toshifumi Yodoshi, Mikihiro Inoue, Shigeo Nishimata, Hitoshi Tajiri, Eitaro Hiejima, Mika Sasaki, Sawako Kato, Hirotaka Shimizu, Yuri Hirano, Toshiaki Shimizu, Katsuhiro Arai, Japanese Pediatric Inflammatory Bowel Disease Registry (JPIBD-R)
Received September 1, 2025  Accepted December 22, 2025  Published online February 24, 2026  
DOI: https://doi.org/10.5217/ir.2025.00203    [Epub ahead of print]
AbstractAbstract PDFPubReaderePub
Background/Aims
Very early-onset inflammatory bowel disease (VEO-IBD), defined as IBD diagnosed before 6 years of age, is highly influenced by genetic factors. Monogenic IBD is a type of enterocolitis caused by a single pathogenic variant. However, information on Asian patients with VEO-IBD and monogenic IBD is limited. This study investigated real-world data on VEOIBD and monogenic IBD in Japan.
Methods
We evaluated patients with VEO-IBD registered in the Japanese Pediatric Inflammatory Bowel Disease Registry, a multicenter prospective registry study conducted between 2012 and 2021. We categorized patients into monogenic and non-monogenic IBD groups and compared their clinical characteristics and outcomes.
Results
Among 703 pediatric patients with IBD, 68 (9.7%) had VEO-IBD. Of these, 26 (38.2%) had ulcerative colitis, 16 (23.5%) had Crohn’s disease, 23 (33.8%) had unclassified IBD (IBD-U), and 3 (4.4%) had Behçet’s disease. Genetic testing was performed in 25 patients (36.8%), and monogenic IBD was identified in 5 of the 23 patients with IBD-U (7.4% of the VEO-IBD cohort). All 5 monogenic cases presented with an IBD-U phenotype. Monogenic IBD included A20 haploinsufficiency, interleukin-10 receptor subunit alpha deficiency, chronic granulomatous disease, Wiskott–Aldrich syndrome, and Hermansky–Pudlak syndrome. Monogenic IBD was significantly associated with IBD-U phenotype (P= 0.015) and severe infections before 1 year of age (P= 0.004).
Conclusions
Patients with VEO-IBD who present an IBD-U phenotype and have a history of severe infections during infancy should be prioritized for genetic analysis to investigate the possibility of monogenic IBD.
  • 1,808 View
  • 87 Download
Close layer
Orofacial granulomatosis in pediatric Crohn’s disease: clinical outcomes and genetic background in the era of biologics: a retrospective study in Japan
Ryusuke Nambu, Takeo Naito, Mei Haruyama, Junichi Hosokawa, Hirotaka Shimizu, Ichiro Takeuchi, Shin-ichiro Hagiwara, Tatsuki Mizuochi, Yugo Takaki, Takashi Ishige, Takuya Nishizawa, Takahiro Kudo, Natsuki Ito, Yosuke Kawai, Yoichi Kakuta, Masao Nagasaki, Toshiaki Shimizu, Itaru Iwama, Katsuhiro Arai
Received June 18, 2025  Accepted September 1, 2025  Published online January 2, 2026  
DOI: https://doi.org/10.5217/ir.2025.00109    [Epub ahead of print]
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Background/Aims
Occasionally, pediatric Crohn’s disease (CD) may develop after diagnosis of orofacial granulomatosis (OFG), which is characterized by chronic granulomatous lesions of the oral mucosa, lips, and perioral area. This study aimed to clarify clinical characteristics, treatment responses, and potential genetic contributors in pediatric patients with CD complicating OFG.
Methods
We studied pediatric patients with CD complicating OFG who were treated from 2013 to 2022 at 7 Japanese institutions specializing in pediatric inflammatory bowel disease. Their clinical courses were analyzed retrospectively, and analyses of 71 genes associated with monogenic inflammatory bowel disease were performed.
Results
Among 13 patients, 8 were girls. Median ages at diagnosis of OFG and CD were 9.2 (3.8–15.3) and 10.3 (6.4–15.3) years old, respectively. Upper gastrointestinal lesions were frequent in 8 cases (62%), while perianal lesions were present in 7 (54%). OFG failed to improve or relapsed despite remission of intestinal lesions in about half of the patients (n = 7, 54%). During follow-up, OFG went into remission in 7 patients, including 6 of the 9 who were treated with biologics (66%) and 1 of the 4 who were not (25%). In 8 patients, the NCF1 p.Arg90His allele was detected by genetic analysis; 7 were heterozygous and 1 homozygous, a higher prevalence than in the general Japanese population.
Conclusions
Clinical features of OFG associated with pediatric CD are diverse, and biologic agents were beneficial for OFG patients. NCF1 p.Arg90His mutation may contribute to the pathogenesis of pediatric CD complicating OFG.
  • 2,592 View
  • 141 Download
Close layer
Inflammatory bowel diseases
Phenotypic characteristics of pediatric inflammatory bowel disease in Japan: results from a multicenter registry
Katsuhiro Arai, Reiko Kunisaki, Fumihiko Kakuta, Shin-ichiro Hagiwara, Takatsugu Murakoshi, Tadahiro Yanagi, Toshiaki Shimizu, Sawako Kato, Takashi Ishige, Tomoki Aomatsu, Mikihiro Inoue, Takeshi Saito, Itaru Iwama, Hisashi Kawashima, Hideki Kumagai, Hitoshi Tajiri, Naomi Iwata, Takahiro Mochizuki, Atsuko Noguchi, Toshihiko Kashiwabara, Hirotaka Shimizu, Yasuo Suzuki, Yuri Hirano, Takeo Fujiwara
Intest Res 2020;18(4):412-420.   Published online August 18, 2020
DOI: https://doi.org/10.5217/ir.2019.00130
AbstractAbstract PDFPubReaderePub
Background/Aims
There are few published registry studies from Asia on pediatric inflammatory bowel disease (IBD). Registry network data enable comparisons among ethnic groups. This study examined the characteristics of IBD in Japanese children and compared them with those in European children.
Methods
This was a cross-sectional multicenter registry study of newly diagnosed Japanese pediatric IBD patients. The Paris classification was used to categorize IBD features, and results were compared with published EUROKIDS data.
Results
A total of 265 pediatric IBD patients were initially registered, with 22 later excluded for having incomplete demographic data. For the analysis, 91 Crohn’s disease (CD), 146 ulcerative colitis (UC), and 6 IBD-unclassified cases were eligible. For age at diagnosis, 20.9% of CD, 21.9% of UC, and 83.3% of IBD-unclassified cases were diagnosed before age 10 years. For CD location, 18.7%, 13.2%, 64.8%, 47.3%, and 20.9% were classified as involving L1 (ileocecum), L2 (colon), L3 (ileocolon), L4a (esophagus/stomach/duodenum), and L4b (jejunum/proximal ileum), respectively. For UC extent, 76% were classified as E4 (pancolitis). For CD behavior, B1 (non-stricturing/non-penetrating), B2 (stricturing), B3 (penetrating), and B2B3 were seen in 83.5%, 11.0%, 3.3%, and 2.2%, respectively. A comparison between Japanese and European children showed less L2 involvement (13.2% vs. 27.3%, P< 0.01) but more L4a (47.3% vs. 29.6%, P< 0.01) and L3 (64.8% vs. 52.7%, P< 0.05) involvement in Japanese CD children. Pediatric perianal CD was more prevalent in Japanese children (34.1% vs. 9.7%, P< 0.01).
Conclusions
Upper gastrointestinal and perianal CD lesions are more common in Japanese children than in European children.

Citations

Citations to this article as recorded by  
  • Diagnosis of Pediatric Inflammatory Bowel Disease (PIBD)–Implications for the Asia-Pacific Region: A Position Paper from the Asian Pan-Pacific Society for Pediatric Gastroenterology, Hepatology, and Nutrition PIBD Working Group
    Rohan Malik, Marion M Aw, Way Seah Lee, Andy Darma, Pornthep Tanpowpong, Nuthapong Ukarapol, James Guoxian Huang, Hong Ngoc Tran, Yen Hsuan Ni
    Pediatric Gastroenterology, Hepatology & Nutrition.2026; 29(1): 22.     CrossRef
  • Real-world outcomes of ustekinumab, vedolizumab, and tumor necrosis factor inhibitors in very-early-onset inflammatory bowel disease: a multi-center cohort study
    Ryusuke Nambu, Itaru Iwama, Ichiro Takeuchi, Shin-ichiro Hagiwara, Yuri Etani, Emiri Kaji, Atsushi Yoden, Fumihiko Kakuta, Yusuke Hoshi, Naoya Tsumura, Tatsuki Mizuochi, Hideki Kumagai, Koji Yokoyama, Takuya Nishizawa, Masaaki Usami, Yugo Takaki, Ryo Eban
    Journal of Gastroenterology.2026; 61(4): 398.     CrossRef
  • Predictive Factors for Abnormal Diagnostic Colonoscopy Findings among Pediatric Patients: A Retrospective Cohort Study
    Kazuki Honjo, Keita Murakami, Junya Arai, Sozaburo Ihara, Hiroyuki Hisada, Dai Kubota, Ken Kurokawa, Yu Miyakawa, Mayo Tsuboi, Yuko Miura, Daisuke Ohki, Hiroya Mizutani, Chihiro Takeuchi, Seiichi Yakabi, Nobumi Suzuki, Hiroto Kinoshita, Yoku Hayakawa, Nao
    Digestive Diseases.2026; 44(2): 216.     CrossRef
  • Phenotypic Presentation of Pediatric Inflammatory Bowel Disease Through 4 Decades: The Pediatric NorDIBD Cohort
    Mads Lie, Søren Raunsgaard Skjernaa, Karoline Mathilde Mose Klitgaard, Helene Sass Michno, Klaus Birkelund Johansen, Lone Larsen, Tine Jess
    American Journal of Gastroenterology.2026;[Epub]     CrossRef
  • Presentation and Clinical Outcomes of Inflammatory Bowel Disease in Children and Adolescents at a Tertiary Care Center in Lebanon
    Tracy Daoud, Sarah Khafaja, Rima Hanna-Wakim, Nadine Yazbeck
    Journal of Clinical Medicine.2026; 15(13): 5105.     CrossRef
  • Long‐term clinical and endoscopic outcomes of ustekinumab in pediatric Crohn's disease with anti‐tumor necrosis factor failure
    Yoko Yamamoto, Ichiro Takeuchi, Hirotaka Shimizu, Hiroki Fujikawa, Masanori Toda, Eri Miyata, Hiroaki To, Satoru Nagata, Katsuhiro Arai
    Journal of Gastroenterology and Hepatology.2025; 40(1): 123.     CrossRef
  • Outcome of pediatric inflammatory bowel disease in Asian children: a multinational 1-year follow-up study
    Pornthep Tanpowpong, Suporn Treepongkaruna, James Guoxian Huang, Kee Seang Chew, Karen Sophia Calixto Mercado, Almida Reodica, Shaman Rajindrajith, Wathsala Hathagoda, Yoko Kin Yoke Wong, Way Seah Lee, Marion Margaret Aw
    Clinical and Experimental Pediatrics.2025; 68(3): 247.     CrossRef
  • Phenotypic Differences and Clinical Outcomes of South Asian Children With IBD: A Singapore–Malaysia Study From the Asian PIBD Registry Network
    James Guoxian Huang, Kee Seang Chew, Veena Logarajah, Way Seah Lee, Marion Margaret Aw
    Journal of Gastroenterology and Hepatology.2025; 40(8): 1933.     CrossRef
  • Expert consensus on diagnostic guidelines for pediatric inflammatory bowel disease in Japan
    Takahiro Kudo, Katsuhiro Arai, Itaru Iwama, Shin-ichiro Hagiwara, Takashi Ishige, Koji Yokoyama, Fumihiko Kakuta, Keisuke Jimbo, Hiroki Kondou, Yugo Takaki, Shingo Kurasawa, Hiroki Fujikawa, Yuhki Koike, Fumihito Hirai, Shinya Ashizuka, Kenji Watanabe, To
    Journal of Gastroenterology.2025; 60(9): 1118.     CrossRef
  • Two Decades of Pediatric Inflammatory Bowel Disease in North-Western Romania: Phenotypic Characteristics and Diagnostic Trends
    Georgia Valentina Tartamus (Tita), Daniela Elena Serban, Marcel Vasile Tantau
    Journal of Clinical Medicine.2025; 14(13): 4597.     CrossRef
  • Growth impairment in Japanese children with inflammatory bowel disease: A multicenter prospective cohort study
    Hirotaka Shimizu, Ryusuke Nambu, Nao Tachibana, Reiko Kunisaki, Takahiro Kudo, Sawako Kato, Tatsuki Mizuochi, Hideki Kumagai, Mikihiro Inoue, Naomi Iwata, Takeshi Saito, Takashi Ishige, Toshifumi Yodoshi, Atsuko Noguchi, Shigeo Nishimata, Takahiro Mochizu
    Journal of Pediatric Gastroenterology and Nutrition.2025; 81(5): 1216.     CrossRef
  • Pharmacist-Led Shared Decision-Making in a Pediatric Patient with Crohn’s Disease and Growth Failure: A Case Report
    Momoko Konaka-Yamamoto, Ikkou Hirata, Maho Hamaguchi, Yuki Ohta, Ryohkan Funakoshi
    YAKUGAKU ZASSHI.2025; 145(10): 857.     CrossRef
  • Asian–Pacific perspectives on the management of very early-onset inflammatory bowel disease
    Ichiro Takeuchi, Katsuhiro Arai, Pornthep Tanpowpong, Ming-Wei Lai, Andrew S Day, Way Seah Lee, James Guoxian Huang, Karen Sophia Calixto-Mercado, Rosanna Ming Sum Wong, Muhammad Arshad Alvi, Zubin Grover, Jung Ok Shim, Ujjal Poddar
    Intestinal Research.2025; 23(4): 405.     CrossRef
  • Inflammatory Bowel Disease in Jordanian Children: A Tertiary Center Experience
    Hala Almomani, Ayah Alsmadi, Nicole Issi, Maria AlShurman, Eyad Altamimi
    Pediatric Gastroenterology, Hepatology & Nutrition.2025; 28(6): 393.     CrossRef
  • Utility of Small Bowel Capsule Endoscopy and Leucine-Rich Alpha-2-Glycoprotein in Pediatric Crohn’s Disease Management
    Satoshi Ukai, Shun Watanabe, Ayako Furuya, Tomomitsu Sado, Shingo Kurasawa, Atsuhiro Hirayama, Sawako Kato, Yoshiko Nakayama
    Cureus.2025;[Epub]     CrossRef
  • Prognosis of pediatric ulcerative colitis after infliximab failure: A multicenter registry‐based cohort study
    Ryusuke Nambu, Takahiro Kudo, Nao Tachibana, Hirotaka Shimizu, Tatsuki Mizuochi, Sawako Kato, Mikihiro Inoue, Hideki Kumagai, Takashi Ishige, Reiko Kunisaki, Atsuko Noguchi, Toshifumi Yodoshi, Shin‐Ichiro Hagiwara, Shigeo Nishimata, Fumihiko Kakuta, Takes
    Journal of Gastroenterology and Hepatology.2024; 39(2): 312.     CrossRef
  • Prevalence of Inflammatory Bowel Disease Unclassified, as Estimated Using the Revised Porto Criteria, among Korean Pediatric Patients with Inflammatory Bowel Disease
    Sung Hee Lee, Minsoo Shin, Seo Hee Kim, Seong Pyo Kim, Hyung-Jin Yoon, Yangsoon Park, Jaemoon Koh, Seak Hee Oh, Jae Sung Ko, Jin Soo Moon, Kyung Mo Kim
    Pediatric Gastroenterology, Hepatology & Nutrition.2024; 27(4): 206.     CrossRef
  • Clinical Efficacy and Future Application of Indigo Naturalis in the Treatment of Ulcerative colitis
    Dianzhen Wu, Qi Huang, Yingbi Xu, Ruiyi Cao, Ming Yang, Jin Xie, Dingkun Zhang
    Journal of Ethnopharmacology.2024; : 118782.     CrossRef
  • Validation of the simplified PIBD‐classes criteria: A single‐center retrospective study
    Yoshikazu Miura, Shin‐ichiro Hagiwara, Keinosuke Hizuka, Ryutaro Saura, Ayaha Hata, Takatoshi Maeyama, Yuri Etani
    Pediatrics International.2024;[Epub]     CrossRef
  • Comparison of Clinical Outcomes in Pediatric Patients with Ileocolonic Crohn Disease Treated with Infliximab Versus Adalimumab
    Eliana Fanous, Tal Marshanski, Noa Tal, Manar Matar, Yael Weintraub, Raanan Shamir, Dror S. Shouval
    Journal of Pediatric Gastroenterology and Nutrition.2023; 77(3): 358.     CrossRef
  • Caracterización clínica y terapéutica de una cohorte multicéntrica de pacientes con enfermedad inflamatoria intestinal en Colombia
    Viviana Parra-Izquierdo, Cristian Flórez Sarmiento, Juan Sebastián Frías-Ordoñez, Melquicedec Vargas, Joshua Kock, Natalia Lozano Escobar, Juan Ricardo Márquez
    Gastroenterología y Hepatología.2023; 46(8): 585.     CrossRef
  • Potential of Gut Microbe-Derived Extracellular Vesicles to Differentiate Inflammatory Bowel Disease Patients from Healthy Controls
    Min Heo, Young Soo Park, Hyuk Yoon, Nam-Eun Kim, Kangjin Kim, Cheol Min Shin, Nayoung Kim, Dong Ho Lee
    Gut and Liver.2023; 17(1): 108.     CrossRef
  • Medical management of pediatric inflammatory bowel disease in the Asia‐Pacific region: A position paper by the Asian Pan‐Pacific Society for Pediatric Gastroenterology, Hepatology, and Nutrition (APPSPGHAN) PIBD Working Group
    Way Seah Lee, Katsuhiro Arai, George Alex, Suporn Treepongkaruna, Kyung Mo Kim, Chee Liang Choong, Karen S. C. Mercado, Andy Darma, Anshu Srivastava, Marion M. Aw
    Journal of Gastroenterology and Hepatology.2023; 38(4): 523.     CrossRef
  • Clinical outcome of ulcerative colitis with severe onset in children: a multicenter prospective cohort study
    Ryusuke Nambu, Katsuhiro Arai, Takahiro Kudo, Takatsugu Murakoshi, Reiko Kunisaki, Tatsuki Mizuochi, Sawako Kato, Hideki Kumagai, Mikihiro Inoue, Takashi Ishige, Takeshi Saito, Atsuko Noguchi, Toshifumi Yodoshi, Shin-Ichiro Hagiwara, Naomi Iwata, Shigeo N
    Journal of Gastroenterology.2023; 58(5): 472.     CrossRef
  • Mucosal immune systems of pediatric inflammatory bowel disease: A review
    Takahiro Kudo, Toshiaki Shimizu
    Pediatrics International.2023;[Epub]     CrossRef
  • Clinical and therapeutic characterisation of a multicentre cohort of patients with inflammatory bowel disease in Colombia
    Viviana Parra-Izquierdo, Cristian Flórez Sarmiento, Juan Sebastián Frías-Ordoñez, Melquicedec Vargas, Joshua Kock, Natalia Lozano Escobar, Juan Ricardo Márquez
    Gastroenterología y Hepatología (English Edition).2023; 46(8): 585.     CrossRef
  • Clinical characteristics and nursing diagnoses of pediatric patients hospitalized with inflammatory bowel disease: a single-center retrospective study in South Korea
    Sung-Yoon Jo, Kyung-Sook Bang
    Child Health Nursing Research.2023; 29(3): 218.     CrossRef
  • Clinical Features and Long-Term Outcomes of Paediatric-Onset Inflammatory Bowel Disease in a Population-Based Cohort in the Songpa-Kangdong District of Seoul, Korea
    Sang Hyoung Park, Jong Pil Im, Hyunju Park, Seung Kyu Jeong, Ji Hyun Lee, Kyoung Hoon Rhee, Young-Ho Kim, Sung Noh Hong, Kyung Ho Kim, Seung In Seo, Jae Myung Cha, Sun Yong Park, Joo Sung Kim, Hyuk Yoon, Sung Hoon Kim, Jisun Jang, Jeong Hwan Kim, Seong O
    Journal of Crohn's and Colitis.2022; 16(2): 207.     CrossRef
  • Long-term Disease Course of Crohn’s Disease: Changes in Disease Location, Phenotype, Activities, and Predictive Factors
    Choong Wui Cho, Myung-Won You, Chi Hyuk Oh, Chang Kyun Lee, Sung Kyoung Moon
    Gut and Liver.2022; 16(2): 157.     CrossRef
  • Symptom Improvement of ulceRative colitis after an Induction dose of UStekinumab in Japanese clinical practice (SIRIUS), measured using patient-reported outcomes: a prospective observational study
    Katsuyoshi Matsuoka, Katsumasa Nagano, Shinya Nagasaki, Yoko Murata, Tadakazu Hisamatsu
    BMJ Open.2022; 12(5): e060081.     CrossRef
  • Personalized medicine in inflammatory bowel disease: Perspectives on Asia
    Su Hyun Park, Sang Hyoung Park
    Journal of Gastroenterology and Hepatology.2022; 37(8): 1434.     CrossRef
  • Phenotypic Pattern of Early Versus Later‐Onset Pediatric Inflammatory Bowel Disease in a Eurasian Country
    Bilge S. Akkelle, Deniz Ertem, Burcu Volkan, Engin Tutar
    Journal of Pediatric Gastroenterology and Nutrition.2022;[Epub]     CrossRef
  • Clinical features of very early-onset inflammatory bowel disease in Japan: a retrospective single-center study
    Masaaki Usami, Ichiro Takeuchi, Reiko Kyodo, Yuri Hirano, Kosuke Kashiwagi, Hiroki Fujikawa, Hirotaka Shimizu, Toshinao Kawai, Katsuhiro Arai
    Intestinal Research.2022; 20(4): 475.     CrossRef
  • SYSTEMATIC REVIEW AND META - ANALYSIS OF THE FREQUENCY AND RE-CLASSIFICATION TRENDS OF PEDIATRIC INFLAMMATORY BOWEL DISEASE - UNCLASSIFIED
    Rishi BOLIA, Akhil Dhanesh GOEL
    Arquivos de Gastroenterologia.2022; 59(4): 531.     CrossRef
  • Comparison between Pediatric Crohn’s Disease and Ulcerative Colitis at Diagnosis in Korea: Results from a Multicenter, Registry-Based, Inception Cohort Study
    Sowon Park, Ben Kang, Seung Kim, Sujin Choi, Hyo Rim Suh, Eun Sil Kim, Ji Hyung Park, Mi Jin Kim, Yon Ho Choe, Yeoun Joo Lee, Jae Hong Park, Eell Ryoo, Hong Koh, Byung-Ho Choe
    Gut and Liver.2022; 16(6): 921.     CrossRef
  • Epidemiology and diagnosis of inflammatory bowel diseases
    Kang-Moon Lee
    Journal of the Korean Medical Association.2021; 64(9): 579.     CrossRef
  • Very early onset inflammatory bowel disease in a South Asian country where inflammatory bowel disease is emerging: a distinct clinical phenotype from later onset disease
    Rupa Banerjee, Partha Pal, Zaheer Nabi, Upender Shava, Girish Ganesh, D. Nageshwar Reddy
    Intestinal Research.2021; 19(4): 398.     CrossRef
  • Incidentally Detected Asymptomatic Perianal Abscess in an Adolescent during Crohn's Disease Diagnosis: Is Routine Pelvic Imaging Required in Korean Pediatric Patients at Diagnosis?
    Soo Hyun Um, Sang Woo Lee, Ki Hwan Song, So Mi Lee, Byung-Ho Choe, Yoo Min Lee, Ben Kang
    Pediatric Gastroenterology, Hepatology & Nutrition.2021; 24(6): 564.     CrossRef
  • 10,802 View
  • 234 Download
  • 34 Web of Science
  • 38 Crossref
Close layer

Intest Res : Intestinal Research
Close layer
TOP